Skip to content

RVMD

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$190.90
−3.07%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 4, 2026
EPS estimate
-$2.41
Revenue estimate
$19.4M

Latest reported

Last report date
Aug 5, 2026
EPS actual
-$3.06
EPS estimate
-$2.04
Revenue actual
Revenue estimate
$1.8M

Track record

Trailing twelve quarters

EPS beats (12Q)
1
EPS misses (12Q)
10
EPS in line (12Q)
1
Avg surprise (4Q)
-26.9%
Revenue beats (12Q)
3

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$251
PT range
$179 – $320
Analysts
13
12 Buy1 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 5, 2026-$2.04-$3.06Miss -50.00%
May 6, 2026-$1.83-$2.29Miss -25.14%
Feb 25, 2026-$1.56-$1.86Miss -19.23%
Nov 5, 2025-$1.42-$1.61Miss -13.38%
Aug 6, 2025-$0.94-$1.31Miss -39.36%
May 7, 2025-$1.12-$1.13Miss -0.89%
Feb 26, 2025-$1.01-$1.12Miss -10.89%
Feb 26, 2024-$0.86-$1.14Miss -32.56%$742.0K
Feb 27, 2023-$0.84-$0.63Beat 25.00%$15.3M
Feb 28, 2022-$0.65-$0.71Miss -9.23%$9.5M
Nov 10, 2021-$0.62-$0.72Miss -16.13%$1.1M
Aug 11, 2021-$0.55-$0.60Miss -9.09%$8.7M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026